Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin infusion to prevent overt hepatic encephalopathy after TIPS
2012-000931-20Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of albumin (human) in hepatic encephalopathy (HE) and Cirrhosis, sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Occurrence of overt hepatic encephalopathy within one month after TIPS. Started Jul 2012; status: active.
02
Drugs
albumin (human)
03
Conditions
hepatic encephalopathy (HE)Cirrhosis
Beyond the preview
Go deeper on 2012-000931-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000931-20.